Food and Drug Administration Public Hearing on the Draft Guidance for Exception from Informed Consent Requirements for Emergency Research: Testimony of Novo Nordisk
2007 ◽
Vol 14
(4)
◽
pp. e71-e73
◽
2007 ◽
Vol 14
(4)
◽
pp. e63-e68
◽
2007 ◽
Vol 14
(4)
◽
pp. e37-e39
◽
Keyword(s):
1999 ◽
Vol 33
(2)
◽
pp. 218-223
◽
2010 ◽
Vol 20
(6)
◽
pp. 1125-1131
◽
Keyword(s):
1999 ◽
Vol 33
(2)
◽
pp. 224-229
◽
Keyword(s):